Akutní nízkotlaká evakuace v managementu extravazačních poranění – kazuistika

Stáhnout PDF

Autoři: Van Look L ¹; Vissers G. ^1,2; Tondu T. ^1,2; Thiessen F. ^1,2
Působiště autorů: Faculty of Medicine and Health Sciences, Antwerp University, Wilrijk, Belgium ¹; Department of Plastic, Reconstructive and Aesthetic Surgery, University Hospital Antwerp, Edegem, Belgium ²
Vyšlo v časopise: ACTA CHIRURGIAE PLASTICAE, 64, 1, 2022, pp. 44-49
doi: https://doi.org/10.48095/ccachp202244

Zdroje

1. Alexander L. Extravasation injuries: a trivial injury often overlooked with disastrous consequences. World J Plast Surg. 2020, 9(3): 326–330.

2. Kumar RJ., Pegg SP., Kimble RM. Management of extravasation injuries. ANZ J Surg. 2001, 71(5): 285–289.

3. Doornaert M., Monstrey S., Roche N. Extravasation injuries: current medical and surgical treatment. Acta Chir Belg. 2013, 113(1): 1–7.

4. Gault DT. Extravasation injuries. Br J Plast Surg. 1993, 46(2): 91–96.

5. Haslik W., Hacker S., Felberbauer FX., et al. Port-a-cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy. Eur J Surg Oncol. 2015, 41(3): 378–385.

6. Barutca S., Kadikoylu G., Bolaman Z., et al. Extravasation of paclitaxel into breast tissue from central catheter port. Support Care Cancer. 2002, 10(7): 563–565.

7. Hartkamp A., van Boxtel AJ., Zonnenberg BA., et al. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med. 2000, 57(6): 215–523.

8. Boussen H., Mtaallah M., Dhiab T., et al. Evaluation of implantable sites in medical oncology in Tunisia. Prospective study of 205 cases. Ann Fr Anesth Reanim. 2001, 20(6): 509–513.

9. Schulmeister L., Camp-Sorrell D. Chemotherapy extravasation from implanted ports. Oncol Nurs Forum. 2000, 27(3): 531–538.

10. Park HJ., Kim KH., Lee HJ., et al. Compartment syndrome due to extravasation of peripheral parenteral nutrition: extravasation injury of parenteral nutrition. Korean J Pediatr. 2015, 58(11): 454–458.

11. Davidoss NH., Ha JF. Extravasation of parenteral nutrition in the neck: a case report. Gen Int Med Clin Innov. 2017, 2(3): 1–3.

12. El Saghir NS., Otrock ZK. Docetaxel extravasation into the normal breast during breast cancer treatment. Anticancer Drugs. 2004, 15(4): 401–404.

13. Gil ME., Mateu J. Treatment of extravasation from parenteral nutrition solution. Ann Pharmacother. 1998, 32(1): 51–55.

14. Vandeweyer E., Deraemaecker R. Early surgical suction and washout for treatment of cytotoxic drug extravasations. Acta Chir Belg. 2000, 100(1): 37–38.

15. Clark KR., Higgs MJ. Breast abscess following central venous catheterization. Intensive Care Med. 1991, 17(2): 123–124.

16. Chang PH., Wang MT., Chen YH., et al. Docetaxel extravasation results in significantly delayed and relapsed skin injury: a case report. Oncol Lett. 2014, 7(5): 1497–1498.

17. Das CK., Gogia A. Vinorelbine-induced chemotherapy port extravasation. Lancet Oncol. 2016, 17(12): e568.

18. Hagopian TM., Ghareeb PA., Arslanian BH., et al. Breast necrosis secondary to vasopressor extravasation: management using indocyanine green angiography and omental flap closure. Breast J. 2015, 21(2): 185–188.

19. Lokich J. Doxil extravasation injury: a case report. Ann Oncol. 1999, 10(6): 735–736.

20. Raymond E., Cartier S., Canuel C., et al. Extravasation of paclitaxel (Taxol). Rev Med Interne. 1995, 16(2): 141–142.

21. Vasconcelos I., Schoenegg W. Massive breast necrosis after extravasation of a full anthracycline cycle. BMJ Case Rep. 2013, 2013: bcr2013201179.